Men, X., Taylor, Z. L., Marshe, V. S., Blumberger, D. M., Karp, J. F., Kennedy, J. L., Lenze, E. J., Reynolds, C. F., Stefan, C., Mulsant, B. H., Ramsey, L. B., & Müller, D. J. (2024). CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression. Clinical Pharmacology & Therapeutics, 115(5), 1065–1074. Portico. https://doi.org/10.1002/cpt.3162

Chiwambutsa, S. M., Ayeni, O., Kapungu, N., Kanji, C., Thelingwani, R., Chen, W. C., Mokone, D. H., O’Neil, D. S., Neugut, A. I., Jacobson, J. S., Ruff, P., Cubasch, H., Joffe, M., & Masimirembwa, C. (2023). Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co‐Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer. Clinical Pharmacology & Therapeutics, 114(1), 127–136. Portico. https://doi.org/10.1002/cpt.2904